Inventor · Pearl River, NY, US

Thomas Nittoli

35Patents
6h-index
41Co-inventors
69Inventor score

Filing activity: Oct 9, 2001 → May 12, 2023

Most-cited inventions

PatentTitleAreaCited byStatus
US10738130B2 Bispecific antigen-binding molecules that bind MUC16 and CD3, and compositions thereof Physics 38 Active
US10772972B2 Anti-STEAP2 antibody drug conjugates, and compositions and uses thereof Chemistry; Metallurgy 38 Active
US9302015B2 Anti-PRLR antibodies and methods for killing PRLR-expressing cells Chemistry; Metallurgy 22 Active
US9950076B2 Maytansinoid derivatives, conjugates thereof, and methods of use Chemistry; Metallurgy 19 Active
US9951141B2 Antibody-drug conjugates, their preparation and their therapeutic use Chemistry; Metallurgy 9 Active
US9475875B2 Anti-EGFRvIII antibodies and uses thereof Chemistry; Metallurgy 8 Active
US10570151B2 Biologically active molecules, conjugates thereof, and therapeutic uses Human Necessities 6 Active
US10463749B2 Maytansinoid derivatives, conjugates thereof, and methods of use Chemistry; Metallurgy 4 Active
US9545451B2 Anti-PRLR antibodies and methods for killing PRLR-expressing cells Chemistry; Metallurgy 4 Active
US10738124B2 Anti-EGFRvIII antibodies and uses thereof Chemistry; Metallurgy 2 Active
US9688764B2 Methods of treating breast cancer by administering anti-human prolactin receptor (PRLR) antibodies Chemistry; Metallurgy 2 Active
US10106616B2 Antagonist antibodies to human prolactin receptor (PRLR) Chemistry; Metallurgy 1 Active
US10047160B2 Anti-EGFRvIII antibodies and uses thereof Chemistry; Metallurgy 1 Active
US11377502B2 Anti-MSR1 antibodies and methods of use thereof Chemistry; Metallurgy 1 Active
US10941208B2 Anti-MUC16 antibodies Physics 1 Active
US11666658B2 Rifamycin analogs and antibody-drug conjugates thereof Emerging Cross-Sectional Technologies 0 Active
US11866502B2 Anti-FGFR2 antibodies and methods of use thereof Chemistry; Metallurgy 0 Active
US11633501B2 Anti-STEAP2 antibodies, antibody-drug conjugates, and bispecific antigen-binding molecules that bind STEAP2 and CD3, and uses thereof Chemistry; Metallurgy 0 Active
US10683354B2 Antibody-drug conjugates comprising anti-prolactin receptor (PRLR) antibodies and methods of use thereof to kill PRLR-expressing cells Chemistry; Metallurgy 0 Active
US12419963B2 Diels-Alder conjugation methods Human Necessities 0 Active
US10526344B2 Amino acid acylation reagents and methods of using the same Chemistry; Metallurgy 0 Active
US11485793B2 Anti-MUC16 antibodies, antibody-drug conjugates, and bispecific antigen-binding molecules that bind MUC16 and CD3, and uses thereof Physics 0 Active
US6455570B1 Polypyrrolinone based inhibitors of matrix metalloproteases Chemistry; Metallurgy 0 Expired
US11446389B2 Maytansinoid derivatives, conjugates thereof, and methods of use Chemistry; Metallurgy 0 Active
US11345715B2 Biologically active molecules, conjugates thereof, and therapeutic uses Human Necessities 0 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.